BR112014010767A2 - Forma iv do cloridrato de ivabradina - Google Patents

Forma iv do cloridrato de ivabradina

Info

Publication number: BR112014010767A2
Authority: BR; Brazil
Prior art keywords: chloridate; ivabradine; ivabradine chloridate; chloridate form
Prior art date: 2011-11-04

Application number

BR112014010767A

Other languages

English (en)

Other versions

BR112014010767B1 (pt

Inventor

Prohens Lopez Rafael

Original Assignee

Urquima Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-11-04

Filing date

2012-09-21

Publication date

2017-06-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46934559&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014010767(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-09-21 Application filed by Urquima Sa filed Critical Urquima Sa

2017-06-13 Publication of BR112014010767A2 publication Critical patent/BR112014010767A2/pt

2021-03-09 Publication of BR112014010767B1 publication Critical patent/BR112014010767B1/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)

BR112014010767-0A 2011-11-04 2012-09-21 forma iv do cloridrato de ivabradina BR112014010767B1 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP11382339.7A EP2589594A1 (en)	2011-11-04	2011-11-04	Ivabradine hydrochloride Form IV
EP11382339.7		2011-11-04
PCT/EP2012/068615 WO2013064307A1 (en)	2011-11-04	2012-09-21	Ivabradine hydrochloride form iv

Publications (2)

Publication Number	Publication Date
BR112014010767A2 true BR112014010767A2 (pt)	2017-06-13
BR112014010767B1 BR112014010767B1 (pt)	2021-03-09

Family

ID=46934559

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR112014010767-0A BR112014010767B1 (pt)	2011-11-04	2012-09-21	forma iv do cloridrato de ivabradina

Country Status (21)

Country	Link
US (3)	US9139531B2 (pt)
EP (3)	EP2589594A1 (pt)
JP (3)	JP6359971B2 (pt)
KR (1)	KR102050117B1 (pt)
AU (1)	AU2012331395B2 (pt)
BR (1)	BR112014010767B1 (pt)
CA (1)	CA2854549C (pt)
CY (1)	CY1119798T1 (pt)
DK (1)	DK2773620T3 (pt)
ES (1)	ES2562843T3 (pt)
HR (1)	HRP20171511T1 (pt)
HU (1)	HUE034996T2 (pt)
LT (1)	LT2773620T (pt)
MX (1)	MX359288B (pt)
PL (1)	PL2773620T3 (pt)
PT (1)	PT2773620T (pt)
RS (1)	RS56464B1 (pt)
RU (1)	RU2619121C2 (pt)
SI (1)	SI2773620T1 (pt)
WO (1)	WO2013064307A1 (pt)
ZA (1)	ZA201403073B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2589594A1 (en) *	2011-11-04	2013-05-08	Urquima S.A.	Ivabradine hydrochloride Form IV
EP3156399A1 (en) *	2011-11-14	2017-04-19	Cadila Healthcare Limited	Polymorphic forms of ivabradine hydrochloride
ITMI20130684A1 (it) *	2013-04-24	2014-10-25	Chemo Res S L	Nuovo polimorfo del cloridrato di ivabradina e metodo per la sua preparazione
HRP20200300T4 (hr)	2013-03-19	2023-09-15	Chemo Research, S.L.	Novi polimorf ivabradin hidroklorida i metoda za njegovu pripremu
CZ305096B6 (cs)	2013-10-02	2015-04-29	Zentiva, K.S.	Pevná forma Ivabradin hydrochloridu a (S)-mandlové kyseliny a její farmaceutická kompozice
MX363389B (es)	2013-12-12	2019-03-20	Synthon Bv	Composicion farmaceutica que comprende ivabradina amorfa.
EP2774606B1 (en)	2014-02-14	2019-01-30	Synthon B.V.	Pharmaceutical composition comprising ivabradine hydrochloride polymorph IV
CZ305436B6 (cs)	2014-07-10	2015-09-16	Zentiva, K.S.	Pevná forma Ivabradin hydrochloridu a (R)-mandlové kyseliny a její farmaceutická kompozice
GR1008821B (el)	2015-06-11	2016-08-01	Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων	Φαρμακευτικο σκευασμα που περιλαμβανει υδροχλωρικη ιβαμπραδινη και μεθοδος παρασκευης αυτου
TR201703066A2 (tr)	2017-02-28	2018-09-21	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	İvabradi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari
EP3366282A1 (en)	2017-02-28	2018-08-29	Sanovel Ilac Sanayi ve Ticaret A.S.	Solid oral pharmaceutical compositions of ivabradine
US11294199B2 (en)	2017-09-19	2022-04-05	Mitsui Chemicals, Inc.	Eyewear
US20230181472A1 (en) *	2018-10-30	2023-06-15	Amgen Inc.	Process of making ivabradine hydrochloride drug product
IT202000025312A1 (it)	2020-10-26	2022-04-26	Cambrex Profarmaco Milano S R L	Processi per la preparazione di polimorfi di ivabradina hcl

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2681862B1 (fr) *	1991-09-27	1993-11-12	Adir Cie	Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868777B1 (fr)	2004-04-13	2006-05-26	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2882554B1 (fr) *	2005-02-28	2007-05-04	Servier Lab	Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882555B1 (fr)	2005-02-28	2007-05-04	Servier Lab	Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882553B1 (fr)	2005-02-28	2007-05-04	Servier Lab	Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr)	2005-02-28	2007-05-04	Servier Lab	Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2891827B1 (fr) *	2005-10-11	2007-12-28	Servier Lab	Forme cristalline deltad du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2891826B1 (fr)	2005-10-11	2007-12-28	Servier Lab	Forme cristalline 6 du chlorhydrate de l'ivabradine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
ATE544754T1 (de) *	2006-11-30	2012-02-15	Cadila Healthcare Ltd	Verfahren zur herstellung von ivabradinhydrochlorid
WO2008125006A1 (fr) *	2007-04-12	2008-10-23	Utopharm (Shanghai) Co., Ltd	Procédés de préparation du chlorhydrate d'ivabradine et de sa forme cristalline stable
WO2008146308A2 (en)	2007-05-30	2008-12-04	Ind-Swift Laboratories Limited	Process for the preparation of ivabradine hydrochloride and polymorph thereof
CN101597261A (zh)	2008-06-06	2009-12-09	北京深蓝海生物医药科技有限公司	无定形盐酸伊伐布雷定
US20100323471A1 (en)	2008-08-21	2010-12-23	Applied Materials, Inc.	Selective Etch of Laser Scribed Solar Cell Substrate
CN101768117B (zh)	2008-12-29	2014-05-07	北京德众万全药物技术开发有限公司	一种盐酸伊伐布雷定晶型及其制备方法
CN101463008A (zh)	2009-01-11	2009-06-24	山东鲁抗辰欣药业有限公司	盐酸伊伐布雷定无定型物及其制备方法
CN101805289A (zh)	2009-02-17	2010-08-18	成都威克药业有限责任公司	伊伐布雷定盐酸盐的ω-晶型、其制备方法和药物组合物
CN102050784B (zh)	2009-11-04	2014-07-09	扬子江药业集团北京海燕药业有限公司	一种无定型盐酸伊伐布雷定的制备方法
SI23290A (sl)	2010-02-12	2011-08-31	Krka D.D., Novo Mesto	Nove oblike ivabradin hidroklorida
WO2012025940A1 (en)	2010-08-25	2012-03-01	Cadila Healthcare Limited	Polymorphic form of ivabradine hydrochloride and process for preparation thereof
EP2589594A1 (en) *	2011-11-04	2013-05-08	Urquima S.A.	Ivabradine hydrochloride Form IV
EP3156399A1 (en) *	2011-11-14	2017-04-19	Cadila Healthcare Limited	Polymorphic forms of ivabradine hydrochloride

2011
- 2011-11-04 EP EP11382339.7A patent/EP2589594A1/en not_active Withdrawn
2012
- 2012-09-21 EP EP17184888.0A patent/EP3263556A1/en active Pending
- 2012-09-21 MX MX2014005362A patent/MX359288B/es active IP Right Grant
- 2012-09-21 CA CA2854549A patent/CA2854549C/en active Active
- 2012-09-21 ES ES12766056.1T patent/ES2562843T3/es active Active
- 2012-09-21 JP JP2014539268A patent/JP6359971B2/ja active Active
- 2012-09-21 WO PCT/EP2012/068615 patent/WO2013064307A1/en active Application Filing
- 2012-09-21 US US14/356,240 patent/US9139531B2/en active Active
- 2012-09-21 LT LTEP12766056.1T patent/LT2773620T/lt unknown
- 2012-09-21 SI SI201231092T patent/SI2773620T1/sl unknown
- 2012-09-21 BR BR112014010767-0A patent/BR112014010767B1/pt active IP Right Grant
- 2012-09-21 KR KR1020147015092A patent/KR102050117B1/ko active IP Right Grant
- 2012-09-21 DK DK12766056.1T patent/DK2773620T3/en active
- 2012-09-21 PL PL12766056T patent/PL2773620T3/pl unknown
- 2012-09-21 RU RU2014122261A patent/RU2619121C2/ru active
- 2012-09-21 EP EP12766056.1A patent/EP2773620B1/en active Active
- 2012-09-21 PT PT127660561T patent/PT2773620T/pt unknown
- 2012-09-21 HU HUE12766056A patent/HUE034996T2/en unknown
- 2012-09-21 RS RS20171010A patent/RS56464B1/sr unknown
- 2012-09-21 AU AU2012331395A patent/AU2012331395B2/en active Active
2014
- 2014-04-25 ZA ZA2014/03073A patent/ZA201403073B/en unknown
2015
- 2015-07-22 US US14/806,224 patent/US9309201B2/en active Active
2016
- 2016-04-02 US US15/089,495 patent/US20160289192A1/en not_active Abandoned
2017
- 2017-05-30 JP JP2017106708A patent/JP2017178965A/ja not_active Withdrawn
- 2017-10-09 HR HRP20171511TT patent/HRP20171511T1/hr unknown
- 2017-10-12 CY CY20171101069T patent/CY1119798T1/el unknown
2018
- 2018-04-09 JP JP2018074972A patent/JP2018123154A/ja active Pending

Also Published As

Publication number	Publication date
US20140315890A1 (en)	2014-10-23
KR20140101753A (ko)	2014-08-20
WO2013064307A1 (en)	2013-05-10
EP2773620A1 (en)	2014-09-10
PT2773620T (pt)	2017-10-19
RS56464B1 (sr)	2018-01-31
SI2773620T1 (sl)	2017-11-30
EP2773620B1 (en)	2017-08-16
HRP20171511T1 (hr)	2017-11-17
CA2854549C (en)	2019-08-27
EP2589594A1 (en)	2013-05-08
ES2562843T3 (es)	2017-10-19
MX2014005362A (es)	2015-01-22
BR112014010767B1 (pt)	2021-03-09
PL2773620T3 (pl)	2017-12-29
KR102050117B1 (ko)	2020-01-08
EP3263556A1 (en)	2018-01-03
DK2773620T3 (en)	2017-10-09
HUE034996T2 (en)	2018-05-02
CA2854549A1 (en)	2013-05-10
JP2018123154A (ja)	2018-08-09
US20150344435A1 (en)	2015-12-03
US20160289192A1 (en)	2016-10-06
LT2773620T (lt)	2017-10-25
CY1119798T1 (el)	2018-06-27
JP6359971B2 (ja)	2018-07-18
RU2014122261A (ru)	2015-12-10
AU2012331395B2 (en)	2016-11-17
JP2014532673A (ja)	2014-12-08
MX359288B (es)	2018-09-20
ES2562843T1 (es)	2016-03-08
US9309201B2 (en)	2016-04-12
JP2017178965A (ja)	2017-10-05
AU2012331395A1 (en)	2014-05-22
ZA201403073B (en)	2015-03-25
US9139531B2 (en)	2015-09-22
RU2619121C2 (ru)	2017-05-12

Legal Events

Date	Code	Title	Description
2019-04-30	B07D	Technical examination (opinion) related to article 229 of industrial property law	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.
2019-05-14	B06F	Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
2019-12-17	B07E	Notice of approval relating to section 229 industrial property law
2020-01-07	B06U	Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure
2021-01-05	B09A	Decision: intention to grant
2021-03-02	B09X	Decision of grant: republication
2021-03-09	B16A	Patent or certificate of addition of invention granted	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/09/2012, OBSERVADAS AS CONDICOES LEGAIS.

Publication	Publication Date	Title
BR112014010767A2 (pt)	2017-06-13	Forma iv do cloridrato de ivabradina
EP2783332A4 (en)	2015-08-12	INTERACTION MANAGEMENT
ZA201305213B (en)	2022-06-29	Networking between voip-and pstn-calls
BR112013014361A2 (pt)	2016-09-27	forma de dosagem
EP2636562A4 (en)	2014-06-18	MOUNTING STRUCTURE OF VEHICLE INSTRUMENTS
BR112013031112A2 (pt)	2016-11-29	sem titulo
DE112012005067A5 (de)	2014-09-04	Antriebsstrang
DE112012002790A5 (de)	2014-03-13	Antriebsstrang
EP2753839A4 (en)	2016-07-27	decoupler
HK1218435A1 (zh)	2017-02-17	改進的障礙結構
EP2696208A4 (en)	2014-12-10	CONSTRUCTION MACHINES
BR112013030859A2 (pt)	2017-06-06	sem titulo
EP2758815A4 (en)	2015-03-25	RETRO-REFLECTIVE ELEMENTS
PL2714609T3 (pl)	2018-06-29	Warstwa zaporowa przed metalami alkalicznymi
ZA201305677B (en)	2014-07-30	Passage barrier
HK1198841A1 (en)	2015-06-12	Plate-film forming member
GB2497747B (en)	2017-07-12	Improved hanger
PL2726681T3 (pl)	2018-07-31	Przegroda odporna na wstrząsy sejsmiczne
GB201114416D0 (en)	2011-10-05	Straight owl
ZA201404922B (en)	2015-12-23	Retaining walls
AU4758P (en)	2014-01-23	Zapriamin Alstroemeria hybrid
AU4759P (en)	2014-01-23	Zalsaney Alstroemeria hybrid
PL120013U1 (pl)	2012-11-19	Maszyna budowlana
AU4554P (en)	2013-05-16	WES03 Westringia hybrid
GB201111746D0 (en)	2011-08-24	Mats